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December 20121826 AbstractsTable. Patient preoperative variables and perioperative outcomes
Variable
GSV Spliced vein Arm vein Prosthetic Prosthetic/venous adjunct Composite
(n  3983) (n  160) (n  93) (n  889) (n  112) (n  91)
Female, No. (%) 1280 (32.2) 49 (31.2) 23 (24.7) 315 (35.2) 33 (29.7) 39 (42.9)
Age, years 69.5  12.3 71.3  11.2 67.5  10.9 70.6  11.4 70.2  12.0 70.9  11.3
CABG, No. (%) 874 (21.9) 55 (34.4) 43 (46.2) 311 (34.6) 41 (36.6) 22 (24.2)
Transfusion 0.5  1.1 1.2  1.7 0.4  0.8 0.5  1.2 0.7  1.1 0.6  1.2
OR time, hours 4.4  1.8 6.1  1.9 5.1  2.3 3.7  1.6 4.4  1.8 4.7  2.0
Mortality 127 (3.2) 4 (2.5) 2 (2.2) 40 (4.5) 1 (0.9) 4 (4.4)
30-day graft failure, No. (%) 300 (7.5) 9 (5.6) 4 (4.3) 94 (10.5) 11 (9.8) 14 (15.4)
P vs GSV . . . .37 .24 .004 .37 .006a
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tand previous cardiac surgery (coronary artery bypass grafting), the bypass
conduit had a significant independent association with 30-day graft patency
(P  .006). The GSV failure rate was 7.5%. Composite grafts had a
significantly higher 30-day failure rate (15.4%, P  .006). There was no
significant difference in 30-day patency of spliced vein (5.6%, P  .37) or
arm vein (4.3%, P  .24) conduits compared with GSV. However, spliced
vein and arm vein involved longer operating room time, and spliced vein
increased transfusion requirements. Prosthetic grafts had significantly lower
30-day patency compared with GSV (10.5%, P  .004). The addition of
adjuvant venous tissue at the distal anastomosis of prosthetic bypasses did
not significantly improve their 30-day patency (prosthetic/venous adjunct
graft failure rate, 9.8% vs prosthetic graft failure rate, 10.5%).
Conclusions: Venous conduits (GSV, spliced vein, arm vein) deliver
the best perioperative patency for tibial bypass, and GSV remains the most
commonly used graft for tibial revascularization. Prosthetic grafts had a
higher perioperative bypass failure rate. Composite grafts should be aban-
doned because their patency is not better than pure prosthetic conduits. The
addition of a distal venous adjunct did not seem to improve acute prosthetic
graft patency, which may reflect lack of effect on thrombogenicity rather
than the myointimal hyperplastic response that impacts long term failure of
tibial bypass.
Spliced Arm Vein Grafts for Critical Lower Limb Ischemia
Luigi Pascarella, Leila Mureebe, Mitchell W. Cox, Richard L. McCann. Duke
University Medical Center, Durham, NC
Introduction: Many patients with critical limb ischemia do not have
adequate ipsilateral saphenous vein for constructing a bypass due to prior
harvesting for limb or coronary artery bypass grafting or to intrinsic vein
disease. Prosthetic conduits or frozen or tanned homografts have poor
long-term patency, especially for distal bypass. This study reviews our
experience with an alternate conduit using spliced arm veins for bypass of
critical lower limb ischemia.S
mFig.Methods: A retrospective record review was conducted of all patients
t a single institution over an 11-year period. Statistical analysis was con-
ucted by Kaplan-Meier survival analysis and Cox proportional hazards
odel. Statistical significance was set at P  .05.
Results: Since 2001, 33 patients (22 men, 11 women; mean age, 65
ears) with critical limb ischemia underwent 34 bypass operations using a
onduit containing at least one arm vein segment and one or more splices.
ll had rest pain or tissue loss, and 70% had undergone a mean of 1.3 prior
ypass attempts (range, 0-4). Twenty percent of patients had undergone
ttempts at percutaneous revascularization. Conduits consisted of cephalic
ein (n  16), basilic vein (n  32), and residual saphenous vein (n  24)
egments. Six grafts (18%) had two splices. Eighty-five percent of bypasses
ere to tibial vessels. Patency at 1 year was 100% (20 of 20) and at 2 years was
5% (12 of 14, Fig). One patient with a patent stent graft required ampu-
ation, and one patient underwent amputation after graft thrombosis. There
as no statistical impact on amputation or patency based on source of vein,
nflow artery, outflow artery, number of splices or patient age.
Conclusions: Spliced arm vein grafts provide durable lower extremity
evascularization and limb salvage when intact saphenous vein is not avail-
ble. Spliced arm grafts are superior to prosthetic or frozen homografts for
epeat bypass after failure of an initial autogenous graft.
omparison of Long-term Outcomes Following Endovascular Repair
f Abdominal Aortic Aneurysms Based on Size Threshold
harles J. Keith, Jr, Marc A. Passman, Michael J. Gaffud, Zdenek Novak,
arjan U. Mujib, Thomas C. Matthews, Mark A. Patterson, William D.
ordan, Jr. University of Alabama at Birmingham, Birmingham, Ala
Introduction: Size threshold for operative repair of abdominal aortic
neurysms (AAA) has been determined based on risks and outcomes of open
epair vs surveillance. The influence of endovascular repair (EVAR) on this
hreshold is less established. The purpose of this study is to determine
hether long-term outcomes of EVAR are affected bymaximum diameter at
ime of treatment.
Methods:All patients who underwent EVARwithmodular stent grafts
etween January 2000 and December 2011 at a single academic institution
ere identified from a prospectively maintained database. Patients were
tratified based onmaximum aortic diameter at time of repair: small (4.0-4.9
m), medium (5.0-5.9 cm), and large (6.0 cm). Comparisons of demograph-
cs, indications for repair, and perioperative complications were made among
he groups. Long-term follow-up was reviewed for expansion of the native
neurysm sac 5 mm, secondary intervention involving the native aneurysm or
tent graft, and all-cause mortality. Statistical analyses were made using analysis
f variance, 2, and Kaplan-Meier plots.
Results: During the study period, 740 patients underwent EVAR with
odular stent grafts: 157 small (21.2%), 374 medium (50.5%), and 209
arge (28.2%). Preoperative patient characteristics were similar among the
roups with exception to mean age (69.3 8.09, 71.7 8.55, and 73.6
.77 years for small, medium, and large, respectively; P  .001), history of
oronary artery disease (42% small, 57% medium, 51.2% large; P  .01),
rior coronary angioplasty (14.6% small, 18.2% medium, 9.6% large; P 
02), congestive heart failure (5.7% small, 15.2% medium, 19.6% large; P 
01), prior vascular surgery (7% small, 15.8% medium, 10% large; P .016),
nd chronic obstructive pulmonary disease (21% small, 27% medium, 33%
arge; P  .038). Clinical classification differed significantly as a larger
ercentage of small AAAs were symptomatic (19.7% small, 7.5% medium,
.1% large; P  .001). No difference in perioperative complication rates
P .399) or all-type endoleak at any surveillance visit (40.8% small, 41.7%
edium, 44.5% large; P  .73) was observed among the groups. However,
he small AAA group developed fewer type I endoleaks (5.1% vs 6.95%
edium and 14.8% large; P  .001). Aneurysm sac expansion of 5 mm was
bserved in 2.6% of small, 5.6% of medium, and 7.2% of large AAAs during
he follow-up period but did not achieve a significant difference (P .148).
econdary intervention rates differed significantly as 5.1% of small, 7.5% of
edium, and 12.9% large AAAs required secondary intervention (P .018).
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Volume 56, Number 6 Abstracts 1827In direct comparison with small AAAs, medium (P  .39) and large (P 
.001) groups both required secondary intervention more frequently, with
hazard ratios of 2.32 (95% confidence interval, 1.045-5.156) and 4.74 (95%
confidence interval, 2.115-10.637), respectively. Overall 10-year survival
was 72% in the small, 63.1% in the medium, and 49.8% in the large group
(P  .001) with no known AAA-related deaths. Age-adjusted all-cause
mortality differed significantly among the group aged 75 to 84 years (30.4%
small, 51.6% medium, 55.7% large; P  .017).
Conclusions: EVAR for small AAAs demonstrates improved long-term
outcomes when compared with EVAR formedium and large AAAs. These data
suggest that EVAR for AAAs ranging from4 to 5 cmmay have better outcomes
than EVAR for age-matched patients with larger aneurysms.
Percutaneous Endovascular Repair of Juxtarenal Aortic Aneurysm
Using Customized Cook Zenith Fenestrated Stent Graft
Mateus P. Correa, Gustavo S. Oderich. Mayo Clinic, Rochester, Minn
Introduction: Fenestrated endovascular aortic repair (FEVAR) has
been used with increasing frequency to treat juxtarenal aortic aneurysms.We
present the preoperative planning, stent graft design, and technique of
implantation of a Cook Zenith (Cook Inc, Brisbane, Australia) customized
fenestrated stent graft in an 80-year-old woman with an enlarging 6-cm
juxtarenal aortic aneurysm.
Methods: Computed tomography angiography (CTA) with centerline
of flow analysis was used for measurements, and a customized stent graft was
designed with two 6-  8-mm renal artery fenestrations. Under general
anesthesia, bilateral percutaneous transfemoral access was established with
placement of preclosure sutures. After systemic heparinization, a 20F sheath
was introduced via the right transfemoral approach. The sheath valve was
punctured for placement of selective catheters to locate both renal arteries.
The Cook Zenith fenestrated component was oriented extracorporeally,
introduced, and deployed via the left transfemoral approach. The renal
arteries were accessed through the renal fenestrations, and 7F hydrophilic
sheaths were placed over 0.035-inch Rosen wires. A diameter-reducing wire,
which constrained the device, was removed, the uncovered stent was de-
ployed, and the top cap was retrieved. The proximal neck was balloon
dilated. Renal alignment stents were deployed and flared proximally using
10-mm angioplasty balloons. Selective renal arteriographies showed widely
patent renal arteries with no endoleak. The repair was completed with
deployment of a distal bifurcated component via the left transfemoral
approach and a right iliac limb extension. Completion angiography showed
widely patent target vessels, stent grafts, and iliac arteries without endoleak.
Total contrast volume was 62 mL, fluoroscopy was 40 minutes, and oper-
ating time was 82 minutes. The patient was dismissed home the next day
without complications, and a CTA showed no endoleak or stent graft
complications in 18 months of follow-up.
Conclusions: Customized fenestrated stent grafts have expanded the
indications of endovascular repair to include patients with inadequate infra-
renal aortic neck or involvement of the visceral arteries. The technique can
be performed using a total percutaneous approach and has the potential to
reduce mortality, morbidity, blood loss, operative time and hospital stay
compared with open surgical repair.
Long-Term Results for Endovascular Repair of Acute Complicated
Type B Aortic Dissection
Jennifer M. Hanna, Asvin Ganapathi, Nicholas Andersen, Richard L.
McCann, G. ChadHughes. DukeUniversityMedical Center, Durham, NC
Introduction: Despite the lack of current U.S. Food and Drug Ad-
ministration approval for management of acute complicated type B aortic
dissection, thoracic endovascular aortic repair (TEVAR) has replaced open
surgical management for this indication due to promising short-term and
midterm safety and efficacy. However, because of the relatively recent
adoption of this technology, long-term results with a view towards durability
and requirement for secondary procedures are limited. As such, the objective
of this study is to report long-term outcomes of TEVAR for acute (2 weeks
from symptom onset) complicated type B dissection.
Methods: Between July 2005 and June 2012, 47 patients underwent
TEVAR for the management of acute complicated type B dissection at a
single referral institution (Table I). Indications for intervention included
rupture in eight (17%), malperfusion in 23 (49%), and/or refractory pain or
hypertension in 18 (38%; Table II). Fisher exact t test was used to compare
continuous variables, and 2 test was used to compare categoric variables. A
Kaplan-Meier analysis with a log-rank test was used to compare aortic vs
overall survival.
Results: Primary technical success was 100%. In-hospital/30-day rates
of death, stroke, permanent paraplegia/paraparesis, and new dialysis were
0%, 2% (n 1), 2% (n 1), and 4% (n 2), respectively. Overall survival was
83% at 84 months, with none of the late deaths attributable to the aortic
pathology (Fig). The composite reintervention rate related to the index
procedure was 28% (n 13). Median time to reintervention was 4.5 months
(interquartile range, 1.4-8.1 months; Table III).
D
dConclusions: In the largest reported series with the longest follow-up
o date, the current results confirm the excellent short-term outcomes
f TEVAR for acute complicated type B dissection and further demonstrate
hat these results are durable over the long-term as well. The data support
he continued use of TEVAR for acute complicated type B aortic dissection.
able 1. Demographic characteristics and associated comorbidities
ariable
Thoracic endovascular aortic
repair (N47)
edian age (IQR), years 59.0 (53.5-70.5)
ale gender 34 (72%)
edian BMI (IQR) 28.3 (25.1-31.1)
arfan syndrome 4 (9%)
yperlipidemia 22 (47%)
rior aortic surgery 11 (23%)
iabetes mellitus 5 (11%)
istory of hypertension 43 (91%)
obacco use 25 (53%)
hronic obstructive pulmonary disease 6 (13%)
enal insufficiency (cr1.5) 17 (36%)
istory of stroke/TIA 3 (6%)
oronary artery disease 8 (17%)
QR, Interquartile range; BMI, body mass index; Cr, creatinine; TIA,
ransient ischemic attack
able 2. Clinical and radiographic characteristics on admission
ariable
Thoracic endovascular
aortic repair (N47)
BP on admission, mean  SD, mm Hg 156  37
BP on admission, mean  SD, mm Hg 76  22
ypotension/shock on admission 2 (4%)
linical or radiographic malperfusion on
admission
23 (49%)
Visceral malperfusion 11 (23%)
Renal malperfusion 10 (21%)
Iliofemoral malperfusion 12 (26%)
Spinal malperfusion 2 (4%)
resenting aortic symptoms 44 (94%)
Back pain 33 (70%)
Anterior chest pain 22 (47%)
efractory pain/hypertension 18 (38%)
upture 8 (17%)
iameter of descending aorta, mean  SD, cm 4.8  1.0
Fig 1.PB, Diastolic blood pressure; SBP, systolic blood pressure; SD, standard
eviation
